295 related articles for article (PubMed ID: 20693762)
1. [Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].
Hori H
Rinsho Ketsueki; 2010 Jul; 51(7):454-9. PubMed ID: 20693762
[No Abstract] [Full Text] [Related]
2. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
Takeuchi J
Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
[No Abstract] [Full Text] [Related]
3. Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic.
Stary J; Jabali Y; Trka J; Hrusak O; Gajdos P; Hrstkova H; Sterba J; Blazek B; Hak J; Prochazkova D; Cerna Z; Smisek P; Sedlacek P; Vavra V; Mihal V; Hrodek O;
Leukemia; 2010 Feb; 24(2):425-8. PubMed ID: 20016535
[No Abstract] [Full Text] [Related]
4. Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.
Stark B; Nirel R; Avrahami G; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S
Leukemia; 2010 Feb; 24(2):419-24. PubMed ID: 20016534
[No Abstract] [Full Text] [Related]
5. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
7. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
de Bont JM; Holt Bv; Dekker AW; van der Does-van den Berg A; Sonneveld P; Pieters R
Leukemia; 2004 Dec; 18(12):2032-5. PubMed ID: 15483674
[No Abstract] [Full Text] [Related]
8. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
[TBL] [Abstract][Full Text] [Related]
9. [Towards cure for all children with acute lymphoblastic leukemia?].
Baruchel A; Leblanc T; Auclerc MF; Schaison G; Leverger G
Bull Acad Natl Med; 2009 Oct; 193(7):1509-17. PubMed ID: 20669632
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
[TBL] [Abstract][Full Text] [Related]
12. Biology and therapy of childhood acute lymphoblastic leukemia.
Rivera GK; Crist WM; Sallan SE
Rev Invest Clin; 1994 Apr; Suppl():26-33. PubMed ID: 7886304
[No Abstract] [Full Text] [Related]
13. [Treatment strategy for adult acute lymphoblastic leukemia].
Okamoto S
Rinsho Ketsueki; 2002 Jun; 43(6):427-32. PubMed ID: 12134694
[No Abstract] [Full Text] [Related]
14. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
Liu Z; Liu XL; Du QF; Xu N; Zhong M; Song LL; Yi ZS; Liu QF; Meng FY; Zhou SY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):512-5. PubMed ID: 19304540
[TBL] [Abstract][Full Text] [Related]
17. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
Herold R; von Stackelberg A; Hartmann R; Eisenreich B; Henze G
J Clin Oncol; 2004 Feb; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
[No Abstract] [Full Text] [Related]
19. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
20. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
